ARCUS BIOSCIENCES INC's ticker is RCUS and the CUSIP is 03969F109. A total of 133 filers reported holding ARCUS BIOSCIENCES INC in Q3 2021. The put-call ratio across all filers is 0.26 and the average weighting 0.5%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $10,931,298 | -13.3% | 608,986 | -1.9% | 0.00% | 0.0% |
Q2 2023 | $12,603,046 | +24.3% | 620,534 | +11.6% | 0.00% | 0.0% |
Q1 2023 | $10,142,919 | -10.2% | 556,081 | +1.8% | 0.00% | 0.0% |
Q4 2022 | $11,298,499 | +22.3% | 546,349 | +54.7% | 0.00% | 0.0% |
Q3 2022 | $9,236,000 | -37.6% | 353,061 | -39.5% | 0.00% | -50.0% |
Q2 2022 | $14,791,000 | +87.0% | 583,696 | +132.9% | 0.00% | +100.0% |
Q1 2022 | $7,910,000 | -86.4% | 250,630 | -82.5% | 0.00% | -85.7% |
Q4 2021 | $58,049,000 | +1143.8% | 1,434,404 | +971.9% | 0.01% | +600.0% |
Q3 2021 | $4,667,000 | -36.9% | 133,813 | -50.3% | 0.00% | 0.0% |
Q2 2021 | $7,399,000 | +50.9% | 269,458 | +54.3% | 0.00% | 0.0% |
Q1 2021 | $4,902,000 | +299.5% | 174,596 | +269.4% | 0.00% | – |
Q4 2020 | $1,227,000 | +148.4% | 47,262 | +64.0% | 0.00% | – |
Q3 2020 | $494,000 | -78.2% | 28,826 | -68.5% | 0.00% | -100.0% |
Q2 2020 | $2,265,000 | +4933.3% | 91,582 | +2725.7% | 0.00% | – |
Q1 2020 | $45,000 | -90.0% | 3,241 | -92.8% | 0.00% | – |
Q4 2019 | $452,000 | +361.2% | 44,736 | +314.3% | 0.00% | – |
Q3 2019 | $98,000 | -87.5% | 10,797 | -89.1% | 0.00% | – |
Q2 2019 | $785,000 | +528.0% | 98,806 | +879.2% | 0.00% | – |
Q1 2019 | $125,000 | -77.2% | 10,090 | -80.2% | 0.00% | – |
Q4 2018 | $549,000 | +149.5% | 50,936 | +223.5% | 0.00% | – |
Q3 2018 | $220,000 | +50.7% | 15,744 | +31.8% | 0.00% | – |
Q2 2018 | $146,000 | +57.0% | 11,943 | +99.0% | 0.00% | – |
Q1 2018 | $93,000 | – | 6,003 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Invus Financial Advisors, LLC | 1,612,077 | $28,936,782 | 18.14% |
Octagon Capital Advisors LP | 1,968,000 | $35,325,600 | 5.43% |
Decheng Capital Management III (Cayman), LLC | 869,790 | $15,612,731 | 5.21% |
Boxer Capital, LLC | 1,602,200 | $28,759,490 | 1.53% |
SECTORAL ASSET MANAGEMENT INC | 375,456 | $6,739,435 | 1.31% |
DAFNA Capital Management LLC | 222,717 | $3,997,770 | 1.24% |
PFM Health Sciences, LP | 1,405,056 | $25,220,755 | 1.19% |
Ikarian Capital, LLC | 4,000 | $7,180,000 | 0.86% |
Capital Impact Advisors, LLC | 24,280 | $435,826 | 0.73% |
Parkman Healthcare Partners LLC | 205,109 | $3,681,707 | 0.68% |